Podcast

Podcast: This Week in Managed Care - Hint of Medicare Drug Rebates, and Other News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the White House budget director hinted at adding mandatory drug rebates in Medicare; a report found seniors are paying more than ever out-of-pocket for healthcare; and the National Diabetes Prevention Program released promising data from the first 4 years of the program.

Listen below or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Related Videos
John Buse, MD, PhD
SOUL Findings Highlight Cardiovascular Benefits Beyond Glycemic Control With Oral GLP-1
dr jennifer green
Dr Jennifer Green Emphasizes Managing Traditional Risk Factors, Overcoming Clinical Inertia in Patients With Diabetes
dr jennifer green
Dr Jennifer Green Weighs in on CMS Drug Prices, the Future of Combination Therapies
dr ken cohen
Optum Care's Dr Ken Cohen Advocates for Comorbidity-Based GLP-1 Tiering for Patients With Diabetes
dr ian neeland
Comprehensive Care: The Key to Managing Diabetes and Its Complexities
Yael Mauer, MD, MPH
Dr Yael Mauer Details Underlying Mechanisms of GLP-1s, Patient Benefits
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Dr Stacey Ehrenberg: More Research Needed on Use of GLP-1s During Pregnancy
Diana Isaacs, PharmD
Dr Diana Isaacs Surveys Emerging Diabetes, Obesity, and Cardiometabolic Treatment Landscape
Beau Raymond, MD
Dr Beau Raymond: How Ochsner’s Digital Program Promotes Tailored Diabetes Management
Robert Zimmerman, MD
Dr Robert Zimmerman Discusses Challenges, Adverse Effects of GLP-1 and Multi-Agonist Therapies
Related Content
AJMC
April 3rd 2025

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Poorva M. Nemlekar, MS Katia L. Hannah, PhD, MPH Courtney R. Green, PhD Thomas Grace, MD Peter M. Lynch, MPH Jessica R. Castle, MD Gregory J. Norman, PhD
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Continuous glucose monitor. | Image credit: Pixel-Shot – stock.adobe.com
March 26th 2025

CGM Adherence and Costs Improve With DME Channel Over Pharmacy

Hayden E. Klein
A real-world analysis showed a link between continuous glucose monitor (CGM) distribution channel and outcomes for patients with diabetes.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
A recent move by the Trump administration cancelled $400 million in funding, a lot of which was crucial for ongoing scientific and medical research. | image credit: lexiconimages - stock.adobe.com
March 18th 2025

Trump Administration Cancels Crucial Funding for Diabetes Prevention Program

Kyle Munz
Recent cuts to federal grants are set to have a widespread impact across numerous scientific and medical studies.
Female patient and doctor - Dragana Gordic - stock.adobe.com.jpeg
March 14th 2025

Poor Patient-Clinician Communication Linked to Diabetes Care Delays

Pearl Steinzor
This new study has found perceived discrimination in health care leads to delayed visits, especially among younger and minority patients.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo